NEXGEL, Inc. (NXGLW) stock

NXGLWNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as NXGL

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026Score 6/3072% below fair value

$0.01+0.00 (0.00%)

Close on Oct 30, 2026Market cap $34.21MP/E –Yield –

Nexgel EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

Nexgel's EPS for the twelve months ending Jun 30, 2026 was -$0.71. For fiscal 2025 it was -$0.38. The highest annual figure on record is -$0.38 in fiscal 2025.

Annual eps

Period	Period end	Value	Change
FY2025	Dec 31, 2025	-$0.38	–
FY2024	Dec 31, 2024	-$0.50	–
FY2023	Dec 31, 2023	-$0.56	–
FY2022	Dec 31, 2022	-$0.85	–
FY2021	Dec 31, 2021	-$1.45	–
FY2020	Dec 31, 2020	-$1.05	–
FY2019	Dec 31, 2019	-$4.90	–
FY2018	Dec 31, 2018	-$13.30	–

Quarterly eps

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q2 FY2026	Jun 30, 2026	-$0.40	–
Q1 FY2026	Mar 31, 2026	-$0.11	–
Q4 FY2025	Dec 31, 2025	-$0.12	–
Q3 FY2025	Sep 30, 2025	-$0.08	–
Q2 FY2025	Jun 30, 2025	-$0.09	–
Q1 FY2025	Mar 31, 2025	-$0.09	–
Q4 FY2024	Dec 31, 2024	-$0.12	–
Q3 FY2024	Sep 30, 2024	-$0.11	–
Q2 FY2024	Jun 30, 2024	-$0.14	–
Q1 FY2024	Mar 31, 2024	-$0.14	–
Q4 FY2023	Dec 31, 2023	-$0.19	–
Q3 FY2023	Sep 30, 2023	-$0.10	–
Q2 FY2023	Jun 30, 2023	-$0.12	–
Q1 FY2023	Mar 31, 2023	-$0.15	–
Q4 FY2022	Dec 31, 2022	-$0.12	–
Q3 FY2022	Sep 30, 2022	-$0.22	–
Q2 FY2022	Jun 30, 2022	-$0.19	–
Q1 FY2022	Mar 31, 2022	-$0.33	–
Q4 FY2021	Dec 31, 2021	-$0.53	–
Q3 FY2021	Sep 30, 2021	-$0.38	–
Q2 FY2021	Jun 30, 2021	-$0.28	–
Q1 FY2021	Mar 31, 2021	-$0.25	–
Q3 FY2020	Sep 30, 2020	-$0.35	–
Q2 FY2020	Jun 30, 2020	-$0.35	–
Q1 FY2020	Mar 31, 2020	-$0.35	–
Q3 FY2019	Sep 30, 2019	-$0.35	–
Q2 FY2019	Jun 30, 2019	-$7.35	–
Q1 FY2019	Mar 31, 2019	-$4.20	–
Q4 FY2018	Dec 31, 2018	-$4.61	–
Q3 FY2018	Sep 30, 2018	-$5.25	–
Q2 FY2018	Jun 30, 2018	$0.00	–